Bart B Singer, MD
Pathology · Chapel Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 14 years
- Eastern Virginia Medical School, 2012
Offices
1 location · University of North Carolina at Chapel Hill · 2,028 clinicians in this group
Looking this up.
Hospitals listed: Carolina East Medical Center · Chatham Hospital Inc · Unc Hospitals. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Singer’s office at (984) 974-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A141838 · Delinquent
Licence status: Delinquent · since 2016 · expires 2022-04-30 · Eastern Virginia Medical School.
License renewal fee has not been paid. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Carolina East Medical CenterNew Bern, NCAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of CarolinaEast Health SystemPatients rate it 4 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 229.33 (181.78 to 276.88) · 102 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.35, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Chatham Hospital IncSiler City, NCCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of UNC Health Care System, which runs 15 hospitalsPatients rate it 4 of 5 · 86% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Unc HospitalsChapel Hill, NCAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of UNC Health Care System, which runs 15 hospitalsHome of UNC Lineberger Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.685, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.606, Oct 2024 – Sep 2025
See every measure and the patient survey for Carolina East Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 229.33 (181.78 to 276.88) · 102 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.35 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.23 to 2.05) · 1,554 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.6 to 1.13) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 186 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 261 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.8 · 312 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 626 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 725 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 249 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 3,645 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.32) · 8,601 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.08 to 0.44) · 9,203 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.55 to 5.37) · 2,302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0.01 to 2.82) · 1,039 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.79 (1.5 to 4.09) · 2,159 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.75 (2.84 to 12.66) · 1,049 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.09 (1.04 to 7.15) · 1,016 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.83 (0.4 to 3.25) · 409 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.08) · 7,232 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 64 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.949 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.561 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 317 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 761 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.7 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.3 · 691 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.4 · 718 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 744 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.6 to 6.7) · 396 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (9.5 to 14.6) · 396 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 182 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 321 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.6 to 16.8) · 700 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,533 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,125 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Chatham Hospital Inc
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 12.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 310 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24 · 36 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.3 · 39 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 31 cases | None | Jul 2023 – Jun 2025 |
What patients said (204 patients answered, 21% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 85% |
| Staff "always" explained | 73% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 86% |
| Staff "always" explained possible side effects | 59% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Unc Hospitals
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.685 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.606 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.77 (0.02 to 1.52) · 2,693 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.71 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.89 (128.51 to 195.27) · 264 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 408 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.1 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 493 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,907 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.13 to 0.49) · 10,696 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.15 to 0.5) · 11,495 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.29 (1.79 to 4.79) · 3,768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.24) · 1,925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (1.06 to 3.17) · 3,512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (4.9 to 12.87) · 1,760 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.44 (1.13 to 5.76) · 1,918 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.22 to 2.82) · 1,003 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.29 to 1.12) · 9,900 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 189 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.018 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.697 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.637 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 399 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 897 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10.4 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.4 · 451 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.8 · 428 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.5 · 698 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4.6 to 7.2) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (8.2 to 11.7) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.6 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 334 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.4 to 13.9) · 2,091 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,351 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,558 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$34,237
Medicare paid this office $34,237 for 292 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 163 | $8,485 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $6,592 | $58 |
| Pathology examination of specimen during surgery, first tissue block | 25 | $3,975 | $45 |
| Special stained specimen slides to examine tissue, each additional procedure | 42 | $3,862 | $20 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 33 | $3,799 | $115 |
See all 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 163 | $8,485 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $6,592 | $58 |
| Pathology examination of specimen during surgery, first tissue block | 25 | $3,975 | $45 |
| Special stained specimen slides to examine tissue, each additional procedure | 42 | $3,862 | $20 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 33 | $3,799 | $115 |
| Pathology examination of tissue using a microscope, high complexity | 16 | $1,588 | $99 |
| Special stained specimen slides to examine tissue, initial procedure | 57 | $1,513 | $24 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 20 | $1,230 | $62 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $743 | $19 |
| Preparation of tissue for examination by removing any calcium present | 57 | $636 | $8 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 13 | $535 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 22 | $202 | $7 |
| Pathology examination of tissue using a microscope, limited examination | 14 | $48 | $3 |
Who their Medicare patients are
292 Original Medicare patients in 2024. Average age 71 · Under 65 12% · 85 and older 9% · Women 37% · Also on Medicaid 15% · Health risk score 1.56. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Cancer 41% · Diabetes 35% · Coronary heart disease 34% · Chronic kidney disease 30% · Heart failure 25% · COPD 25% · Depression 25% · Atrial fibrillation 18% · Stroke 10% · Dementia 9%.
The office billed $153,440, Medicare allowed $44,833 and paid $34,237; for 1,081 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 292 | 1,081 | 71 | 1.56 | $153,440 | $34,237 |
| 2023 | 335 | 1,283 | 71 | 1.84 | $186,389 | $44,205 |
| 2022 | 352 | 1,313 | 71 | 1.71 | $192,891 | $48,219 |
| 2021 | 438 | 1,716 | 71 | 2.01 | $254,876 | $65,533 |
| 2020 | 400 | 1,481 | 69 | 2.05 | $223,902 | $58,883 |
| 2019 | 675 | 1,782 | 72 | 1.41 | $178,014 | $58,030 |
| 2018 | 1,314 | 2,933 | 72 | 1.07 | $236,343 | $89,453 |
| 2017 | 146 | 620 | 70 | 1.30 | $153,151 | $32,179 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 179 | $10,417 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 87 | $8,274 | $60 |
| Pathology examination of specimen during surgery, first tissue block | 35 | $4,793 | $47 |
| Special stained specimen slides to examine tissue, each additional procedure | 62 | $4,607 | $21 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 37 | $4,116 | $111 |
| Pathology examination of tissue using a microscope, high complexity | 28 | $3,477 | $109 |
| Special stained specimen slides to examine tissue, initial procedure | 81 | $2,383 | $26 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 30 | $2,082 | $63 |
| Pathology examination of specimen during surgery, each additional tissue block | 14 | $1,012 | $23 |
| Preparation of tissue for examination by removing any calcium present | 59 | $770 | $9 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 13 | $662 | $28 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $539 | $20 |
| Pathology examination of tissue using a microscope, moderately low complexity | 24 | $230 | $9 |
2022: 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 189 | $11,243 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 86 | $9,143 | $63 |
| Pathology examination of specimen during surgery, first tissue block | 43 | $6,574 | $47 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 47 | $5,882 | $125 |
| Pathology examination of tissue using a microscope, high complexity | 29 | $3,562 | $108 |
| Special stained specimen slides to examine tissue, each additional procedure | 58 | $3,374 | $21 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 33 | $2,059 | $62 |
| Special stained specimen slides to examine tissue, initial procedure | 69 | $2,031 | $26 |
| Pathology examination of specimen during surgery, each additional tissue block | 13 | $1,508 | $23 |
| Preparation of tissue for examination by removing any calcium present | 50 | $711 | $9 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 18 | $707 | $29 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $608 | $20 |
| Pathology examination of tissue using a microscope, moderately low complexity | 22 | $271 | $9 |
| Pathology examination of tissue using a microscope | 13 | $58 | $4 |
2021: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 245 | $15,252 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 127 | $15,005 | $66 |
| Pathology examination of specimen during surgery, first tissue block | 40 | $8,769 | $50 |
| Pathology examination of tissue using a microscope, high complexity | 44 | $5,624 | $115 |
| Special stained specimen slides to examine tissue, each additional procedure | 72 | $5,309 | $23 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 55 | $3,622 | $66 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 29 | $3,591 | $124 |
| Special stained specimen slides to examine tissue, initial procedure | 102 | $3,073 | $28 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $1,047 | $21 |
| Preparation of tissue for examination by removing any calcium present | 65 | $1,034 | $10 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 14 | $884 | $29 |
| Pathology examination of specimen during surgery, each additional tissue block | 11 | $616 | $25 |
| Genetic sequencing localization, initial procedure | 14 | $489 | $35 |
| Pathology examination of tissue using a microscope, moderately low complexity | 27 | $328 | $9 |
| Pathology examination of tissue using a microscope | 11 | $66 | $6 |
2020: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 220 | $13,956 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 87 | $10,881 | $67 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 50 | $7,425 | $146 |
| Pathology examination of specimen during surgery, first tissue block | 47 | $7,161 | $51 |
| Special stained specimen slides to examine tissue, each additional procedure | 74 | $6,155 | $23 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $3,479 | $120 |
| Special stained specimen slides to examine tissue, initial procedure | 96 | $2,965 | $29 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 37 | $2,445 | $66 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 24 | $1,359 | $32 |
| Special stained specimen slides to identify organisms including interpretation and report | 17 | $875 | $21 |
| Preparation of tissue for examination by removing any calcium present | 50 | $653 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 24 | $253 | $8 |
| Special stained specimen slides to examine tissue including interpretation and report | 12 | $208 | $10 |
2019: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 314 | $16,503 | $32 |
| Pathology examination of tissue using a microscope, moderately high complexity | 91 | $8,936 | $68 |
| Special stained specimen slides to examine tissue, each additional procedure | 69 | $6,042 | $24 |
| Pathology examination of tissue using a microscope, high complexity | 27 | $3,668 | $122 |
| Special stained specimen slides to examine tissue, initial procedure | 104 | $3,462 | $30 |
| Pathology examination of tissue using a microscope, intermediate complexity | 57 | $2,666 | $33 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $2,258 | $51 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 13 | $1,873 | $144 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 23 | $1,548 | $67 |
| Preparation of tissue for examination by removing any calcium present | 115 | $1,281 | $10 |
| Pathology cytologic examination of specimen during surgery, initial site | 21 | $1,186 | $54 |
| Evaluation of fine needle aspirate with interpretation and report | 15 | $1,032 | $61 |
| Pathology examination of tissue using a microscope, moderately low complexity | 99 | $1,023 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 20 | $899 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 12 | $365 | $30 |
| Blood smear interpretation by physician with written report | 11 | $206 | $19 |
| Pathology examination of tissue using a microscope, limited examination | 53 | $198 | $4 |
| Pathology examination of tissue using a microscope | 12 | $68 | $6 |
2018: 27 services
| Pathology examination of tissue using a microscope, intermediate complexity | 451 | $20,009 | $32 |
| Pathology examination of tissue using a microscope, intermediate complexity | 374 | $16,593 | $32 |
| Pathology examination of tissue using a microscope, moderately high complexity | 69 | $6,879 | $72 |
| Special stained specimen slides to examine tissue, each additional procedure | 85 | $6,726 | $24 |
| Pathology examination of tissue using a microscope, moderately high complexity | 38 | $5,901 | $71 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 37 | $5,498 | $149 |
| Special stained specimen slides to examine tissue, initial procedure | 123 | $3,830 | $30 |
| Special stained specimen slides to examine tissue, initial procedure | 64 | $2,478 | $30 |
| Pathology examination of tissue using a microscope, high complexity | 15 | $1,957 | $130 |
| Pathology cytologic examination of specimen during surgery, initial site | 33 | $1,779 | $54 |
| Preparation of tissue for examination by removing any calcium present | 151 | $1,706 | $11 |
| Special stained specimen slides to examine tissue, each additional procedure | 31 | $1,694 | $24 |
| Microscopic genetic analysis of tumor, manual | 18 | $1,662 | $36 |
| Microscopic genetic analysis of tumor, manual | 18 | $1,591 | $38 |
| Pathology examination of tissue using a microscope, moderately low complexity | 150 | $1,551 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 30 | $1,454 | $23 |
| Evaluation of fine needle aspirate with interpretation and report | 20 | $1,285 | $58 |
| Pathology examination of tissue using a microscope, moderately low complexity | 114 | $1,212 | $10 |
| Pathology examination of specimen during surgery, first tissue block | 16 | $978 | $54 |
| Cell examination of specimen, concentration technique | 37 | $769 | $19 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $591 | $19 |
| Preparation of tissue for examination by removing any calcium present | 33 | $386 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 64 | $239 | $4 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $197 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 15 | $182 | $10 |
| Pathology examination of tissue using a microscope | 14 | $85 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 19 | $52 | $3 |
2017: 8 services
| Pathology examination of tissue using a microscope, moderately high complexity | 52 | $10,267 | $80 |
| Pathology examination of tissue using a microscope, intermediate complexity | 79 | $4,256 | $36 |
| Microscopic genetic analysis of tumor, manual | 25 | $3,958 | $52 |
| Pathology examination of specimen during surgery, first tissue block | 24 | $3,917 | $60 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $3,830 | $142 |
| Special stained specimen slides to examine tissue, each additional procedure | 24 | $1,654 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 35 | $1,419 | $34 |
| Pathology examination of tissue using a microscope, moderately low complexity | 31 | $364 | $11 |
Medicaid work
$5,548 in 2024
Medicaid paid $5,548 for 160 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 145 | $5,382 |
| DECALCIFICATION PROCEDURE | 15 | $166 |
| 2024 | 160 | 2 | 23 | $5,548 |
| 2023 | 83 | 1 | 23 | $2,865 |
| 2022 | 136 | 1 | 30 | $6,064 |
| 2021 | 177 | 2 | 28 | $7,487 |
| 2020 | 207 | 3 | 26 | $11,637 |
| 2019 | 182 | 4 | 31 | $8,569 |
| 2018 | 176 | 3 | 38 | $11,796 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 83 | $2,865 |
2022
| TISSUE EXAM BY PATHOLOGIST | 136 | $6,064 |
2021
| TISSUE EXAM BY PATHOLOGIST | 162 | $7,354 |
| DECALCIFICATION PROCEDURE | 15 | $133 |
2020
| TISSUE EXAM BY PATHOLOGIST | 180 | $10,141 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $1,149 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 15 | $347 |
2019
| TISSUE EXAM BY PATHOLOGIST | 122 | $6,575 |
| TISSUE EXAM BY PATHOLOGIST | 32 | $1,737 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $150 |
| DECALCIFICATION PROCEDURE | 15 | $107 |
2018
| TISSUE EXAM BY PATHOLOGIST | 148 | $10,603 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 12 | $670 |
| TISSUE EXAM BY PATHOLOGIST | 16 | $524 |
Money from drug and device companies
$146 in 2025
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | None | $146 | 1 payment
|
See the published payment
| Novartis Pharmaceuticals | Meals · 2025-11-13 | None | $146 |
Professional record
- NPI
- 1396005369
- Licence
- CA 141838, NC 2014-01910California A141838: Delinquent · expires 2022-04-30
- Trained
- Eastern Virginia Medical School, 2012 · 14 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- Unc Pathology Cb 7525 Brinkhous-Bullitt Building, Chapel Hill, NC, 27599
- NPI first listed
- 2012-05-23
- NPI last updated
- 2021-03-31
- NPI record certified
- 2021-03-31
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3701 S Higuera St, San Luis Obispo, CA, 93401 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.